Inner Mongolia Shuangqi Pharmaceutical

Inner Mongolia Shuangqi Pharmaceutical, a subsidiary of Wanze Co., Ltd., is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of microecological preparations (probiotics). The company is a pioneer in the Chinese microbiome industry, best known for its flagship products Siliankang (Bifidobacterium Tetravaccine, Live) and Jinshuangqi, which are used to treat gastrointestinal disorders by restoring gut flora balance. It also produces Dingjunsheng, a probiotic treatment for vaginal health, and Weijianeng (Pidotimod), an immunomodulator. Operating from its base in Hohhot, the company maintains large-scale GMP-certified manufacturing facilities and is a member of the International Scientific Association for Probiotics and Prebiotics (ISAPP). The company plays a significant role in setting industry standards, having participated in drafting the microecological product guidelines for the Chinese Pharmacopoeia.